Improved in vivo tumor therapy via host-guest complexation
Yong Yao1, Yang Wang, Ruibo Zhao
1State Key Laboratory of Chemical Engineering, Center for Chemistry of High-Performance & Novel Materials, Department of Chemistry, Zhejiang University, Hangzhou 310027, P. R. China. fhuang@zju.edu.cn.
Journal of Materials Chemistry. B
|April 9, 2020
Summary
A novel pH-responsive nano-container using host-guest complexation enhances cancer therapy. This system efficiently releases doxorubicin, improving tumor inhibition with fewer side effects.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Conventional chemotherapy faces challenges with toxicity and side effects.
- Developing biocompatible, pH-responsive nano-containers is crucial for improved cancer therapy.
- Novel drug delivery systems are needed to enhance therapeutic efficacy and reduce adverse effects.
Purpose of the Study:
- To design and synthesize a novel nano-container for improved cancer treatment.
- To investigate the pH-responsive drug release mechanism of the nano-container.
- To evaluate the in vivo efficacy and safety of the nano-container for doxorubicin delivery.
Main Methods:
- Synthesis of hollow mesoporous silica nanoparticles (HMNPs) doped with water-soluble pillar[5]arene (WP5).
- Utilizing host-guest complexation between WP5 and HMNPs for drug loading.
- In vivo evaluation of tumor growth inhibition and side effects in a cancer model.
- Investigating the pH-dependent release of doxorubicin from the nano-container.
Main Results:
- The developed nano-container demonstrated efficient loading and pH-responsive release of doxorubicin.
- Significant inhibition of tumor growth in vivo was observed with the novel nano-container.
- The system exhibited minimal side effects, indicating improved biocompatibility and safety.
- Host-guest complexation enhanced drug loading under extracellular conditions and facilitated release in acidic intracellular environments.
Conclusions:
- The WP5-doped HMNPs nano-container is a promising platform for targeted cancer therapy.
- Host-guest complexation offers a viable strategy for developing advanced, pH-responsive drug delivery systems.
- This novel system significantly improves cancer treatment effectiveness while minimizing adverse effects.
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:17The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K